Raymund A. C. Roos

occupation: university teacher

award received: Officer of the order Orange-Nassau

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 177

Date

Title

Authors

2020-11-16

Safety, Pharmacokinetics and Pharmacodynamics of SBT-020 in Patients with Early Stage Huntington's Disease, a two-part study

Marcus P J van Diemen, Hermien E Kan, Andrew Webb, Raymund A. C. Roos, Geert Jan Groeneveld
2019-02-20

Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease ?,Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?

Ralf Reilmann, Ferdinando Squitieri, Raymund A. C. Roos, Sarah J. Tabrizi, Carsten Saft, Bernhard Landwehrmeyer
2019-02-05

Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials

Hans-Jürgen Huppertz, Bernhard Landwehrmeyer, Jan Kassubek, Albert C Ludolph, Sarah J. Tabrizi, Raymund A. C. Roos, Hans-Peter Low-Müller
2018-01-05

The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.

Daniel Zielonka, Jerzy T Marcinkowski, Raymund A. C. Roos, Ferdinando Squitieri, Bernhard Landwehrmeyer
2018-01-24

Neurofilament light protein in blood predicts regional atrophy in Huntington disease.

Filipe B. Rodrigues, Henrik Zetterberg, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Sarah J. Tabrizi, Rachael I. Scahill, Raymund A. C. Roos, Ed Wilding, Eileanoir B. Johnson
2018-01-12

Cognitive Performance and Apathy Predict Unemployment in Huntington's Disease Mutation Carriers.

Milou Jacobs, Raymund A. C. Roos
2018-04-22

Natural biological variation of white matter microstructure is accentuated in Huntington's disease.

Rachael I. Scahill, Douglas R Langbehn, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Geraint Rees, Michael Orth
2018-03-13

Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients.

Raymund A. C. Roos
2018-03-23

Atrophy of the putamen at time of clinical motor onset in Huntington's disease: a 6-year follow-up study.

Raymund A. C. Roos
2018-03-01

Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice.

Raymund A. C. Roos
2018-05-23

Does arterial hypertension influence the onset of Huntington's disease?

Carsten Saft, Asier Fullaondo, Raymund A. C. Roos
2018-07-01

Testing a longitudinal compensation model in premanifest Huntington's disease

Julie C. Stout, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Geraint Rees
2018-10-31

EEG may serve as a biomarker in Huntington's disease using machine learning automatic classification

Raymund A. C. Roos
2018

Altered Intracortical T-Weighted/T-Weighted Ratio Signal in Huntington's Disease

Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill
2018

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study

Alexandra Durr, Blair R Leavitt, David Craufurd, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill
2017-06-07

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Henrik Zetterberg, Kaj Blennow, Filipe B. Rodrigues, Douglas R Langbehn, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill
2017-03-15

The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial

Raymund A. C. Roos, Wilco Achterberg
2017-04-20

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease

Geraint Rees, Eileanoir B. Johnson, Marina Papoutsi, Adeel Razi, Julie C. Stout, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Kiran K Seunarine
2017-01-16

White matter predicts functional connectivity in premanifest Huntington's disease

Marina Papoutsi, Izelle Labuschagne, Adeel Razi, Julie C. Stout, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Geraint Rees, Kiran K Seunarine
2017-02-23

Operationalizing compensation over time in neurodegenerative disease

Lora Minkova, Marina Papoutsi, Adeel Razi, Douglas R Langbehn, Jeffrey Long, Julie C. Stout, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Geraint Rees
2017-08-05

Body weight is a robust predictor of clinical progression in Huntington disease

Albert C. Ludolph, Raymund A. C. Roos, Bernhard Landwehrmeyer
2017-06-19

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Davina J Hensman Moss, Antonio F Pardiñas, Douglas R Langbehn, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Kathrin Reetz, Sang Hong Lee, Anna Sułek-Piątkowska, Oliver Bandmann, Gail Owen
2017-03-15

Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease

Adeel Razi, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Geraint Rees, Kiran K Seunarine
2017-04-19

Driving with a neurodegenerative disorder: an overview of the current literature

Raymund A. C. Roos
2017-05-25

Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes

Raymund A. C. Roos, Sarah J. Tabrizi
2017-08-03

Cognitive decline in Huntington's disease expansion gene carriers

Jennifer C Thompson, Raymund A. C. Roos
2017-09-14

Design optimization for clinical trials in early-stage manifest Huntington's disease.

Amy Mulick Cassidy, Ralf Reilmann, Douglas R Langbehn, Julie C. Stout, Cristina Sampaio, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Chris Frost
2017-11-02

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease

Raymund A. C. Roos
2017-10-26

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.

Peter Holmans, Eileanoir B. Johnson, Marina Papoutsi, Alexandra Durr, Blair R Leavitt, Raymund A. C. Roos, Sarah J. Tabrizi, Rachael I. Scahill, Geraint Rees
2017-12-11

Huntingtin gene repeat size variations affect risk of lifetime depression.

Gerard Van Grootheest, Raymund A. C. Roos, Aartjan T F Beekman, Brenda Penninx
2016-07-26

Music therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial

Raymund A. C. Roos, Wilco Achterberg
2016-12-17

Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease

Raymund A. C. Roos

Human - wd:Q67223099

Welcome to Inventaire

the library of your friends and communities

learn more